TY  - JOUR
T1  - PHarmaceutical benefits managers and optimizing prescribing
AU  - Anderson MJ, Spivack BS
Y1  - 1999/04/07
N1  - 10.1001/jama.281.13.1168
JO  - JAMA
SP  - 1168
EP  - 1168
VL  - 281
IS  - 13
N2  - 
We agree that the drugs and dosages identified by Beers3
generally should be avoided in older adults. Furthermore, physicians
who choose to prescribe these agents must fully appreciate the
associated risks and implement a monitoring plan to regularly review
effectiveness and toxic effects. Express Scripts/ValueRx, Plymouth,
Minn, encourages the application of these principles through our
Seniors Program, which delivers targeted education to physicians
prescribing for older adults. The program materials, delivered via mail
or fax, provide referenced physician education and patient-specific
pharmacy claims history. Physicians are asked to consider the
information provided when prescribing and monitoring therapy for their
older patients.

SN  - 0098-7484
M3  - doi: 10.1001/jama.281.13.1168
UR  - http://dx.doi.org/10.1001/jama.281.13.1168
ER  -